“As scientific knowledge advances and societal views evolve, the clinical use of germline editing should be revisited on a regular basis” 2015 organizing committee of the First International Summit on Human Genome Editing. And here we are at the end of 2018, ‘revisiting’ this for real. I’m writing this while sitting in the audience in … Continue reading →